<?xml version="1.0" encoding="UTF-8"?>
<p id="para0007">Accumulating evidence has revealed that SARS-CoV-2 and SARS-CoV have the same human cell receptor, the angiotensin-converting enzyme 2 (ACE2), while MERS-CoV hinges on dipeptidyl peptidase 4 for host cell entry 
 <xref rid="bib0035" ref-type="bibr">[35]</xref>. ACE2 is a type I membrane protein expressed in the lungs, hearts, kidneys, and intestines, mainly associated with cardiovascular diseases 
 <xref rid="bib0035" ref-type="bibr">[35]</xref>. A recent study analyzed the cryogenic electron microscopy structure of the SARS-CoV-2 S protein unveiled that it exhibits around 10 to 20-fold higher binding affinity to ACE2 in comparison with SARS-CoV 
 <xref rid="bib0036" ref-type="bibr">[36]</xref>. The overall replication cycle of SARS-CoV-2 is depicted in 
 <xref rid="fig0003" ref-type="fig">Fig. 3</xref> .
</p>
